2002Medical Journal of National Defending Forces in Northwest ChinaRequires access

Detection of ANA,anti-ENA antibodies and anti-dsDNA antibodies in lupus erythematosus

Qiang Li

Open publisher page 0 citations

Abstract

Objective:To discuss clinical value and characteristic of antinuclear antibody,anti-ENA antibodies and anti-dsDNA antibodies in lupus erythematosus.Methods:Indirect immunofluorescence was applied to detect ANA and anti-dsDNA antibodies. Antigenic substrate of ANA were liver imprint and Hep-2 cell. Test matrix of dsDNA was crithidia lucilliae flagellate. Detection of anti-ENA antibodies employed edenzyme immunoblotting assays.Results:The positive rate of ANA was 90.4% in SLE and 75% in DLE. The positive rate of anti-dsDNA antibodies was 63.5%,ENA was 84.5%.Conclusion:ANA has nothing to do with activity of SLE. Fluctuations in anti-dsDNA antibody levels are also used as a marker for disease activity and exacerbations.

About this research paper

What this paper is about

Objective:To discuss clinical value and characteristic of antinuclear antibody,anti-ENA antibodies and anti-dsDNA antibodies in lupus erythematosus.Methods:Indirect immunofluorescence was applied to detect ANA and anti-dsDNA antibodies. Antigenic substrate of ANA were liver imprint and Hep-2 cell. Test matrix of dsDNA was crithidia lucilliae flagellate. Detection of anti-ENA antibodies employed edenzyme immunoblotting assays.Results:The positive rate of ANA was 90.4% in SLE and 75% in DLE. The positive rate of anti-dsDNA antibodies was 63.5%,ENA was 84.5%.Conclusion:ANA has nothing to do with activity of SLE. Fluctuations in anti-dsDNA antibody levels are also used as a marker for disease activity and exacerbations.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To discuss clinical value and characteristic of antinuclear antibody,anti-ENA antibodies and anti-dsDNA antibodies in lupus erythematosus.Methods:Indirect immunofluorescence was applied to detect ANA and anti-dsDNA antibodies. Antigenic substrate of ANA were liver imprint and Hep-2 cell. Test matrix of dsDNA was crithidia lucilliae flagellate. Detection of anti-ENA antibodies employed edenzyme immunoblotting assays.Results:The positive rate of ANA was 90.4% in SLE and 75% in DLE. The positive rate of anti-dsDNA antibodies was 63.5%,ENA was 84.5%.Conclusion:ANA has nothing to do with activity of SLE. Fluctuations in anti-dsDNA antibody levels are also used as a marker for disease activity and exacerbations.

Key concepts: Anti-nuclear antibody, Anti-dsDNA antibodies, Antibody, Lupus erythematosus, Immunology, Immunofluorescence, Antigen, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Detection of ANA,anti-ENA antibodies and anti-dsDNA antibodies in lupus erythematosus — Research Paper | ScholarLens